305 | Incentivizing Long-acting Injectable Buprenorphine
Tracks
Workshop
| Thursday, April 11, 2024 |
| 8:30 AM - 9:30 AM |
| Room 208-209 |
Session Overview
Long-acting injectable buprenorphine (Sublocade) works as an extended release MOUD. This life-sustaining medication has helped reduce the risk of overdose and reducing the effects of opioids. Due to the withdrawal struggles and divergence of oral MOUD forms, incentivizing Sublocade has helped increase housing stability, healthcare outcomes and reduce overdoses.
Description
Long-acting injectable buprenorphine (Sublocade) works as an extended release MOUD. This life-sustaining medication has helped reduce the risk of overdose and reducing the effects of opioids. Due to the withdrawal struggles and divergence of oral MOUD forms, incentivizing Sublocade has helped increase housing stability, healthcare outcomes and reduce overdoses.
Kristina Scalia Jackson
Director Of Center Of Excellence
Pathways To Housing Pa
Presenter
Kristina is passionate about bridging the gaps of healthcare services to underrepresented communities. Kristina works to increase equitable access to MOUD, supporting those with substance use disorders through low-barrier, harm reduction approaches. Kristina previously interned with Pathways Integrated Care Clinic, focusing on health care disparities and coordinating Hepatitis C treatment.
